Ipatasertib (GDC-0068) Study to Evaluate Formulation Change and Food Effect on Bioavailability in Healthy Subjects

NCT02536391 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer

Interventions

DRUG: Ipatasertib (capsule)
DRUG: Ipatasertib (tablet)

Sponsor

Genentech, Inc.